Unternehmen
ST. ANNA KINDERKREBSFORSCHUNG GMBH
ST. ANNA KINDERKREBSFORSCHUNG GMBH – Unternehmen mit Aktivitäten in Forschung und Innovation.
Weiter entdecken
Ähnliche Beiträge
Hochschule
→
St. Anna Kinderkrebsforschung GmbH
Beitrag ansehen →
Hochschule
→
SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA
SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA – Hochschule bzw. Forschungseinrichtung mit Aktivitäten in For… Beitrag ansehen →
Projekt
→
Resenha do livro 'Three liability regimes for Artificial Intelligence: algorithmic actants, hybrids, crowds', de Anna Beckers e Gunther Teubner (Oxford: Hart, 2021)
A obra Three Liability Regimes for Artificial Intelligence: Algorithmic Actants, Hybrids, Crowds, de Anna Beckers e Gunther Teubn… Beitrag ansehen →
Hochschule
→
Scuola Superiore Sant'Anna
Scuola Superiore Sant'Anna – Hochschule bzw. Forschungseinrichtung mit Aktivitäten in Forschung und Innovation. Beitrag ansehen →
Projekt
→
Expanding the Properties of Artificial Spider Silk
Spider silk is a material with remarkable biological and mechanical properties. Unfortunately, the cannibalistic nature of spider… Beitrag ansehen →
Projekt
→
Expanding the Properties of Artificial Spider Silk
Spider silk is a material with remarkable biological and mechanical properties. Unfortunately, the cannibalistic nature of spider… Beitrag ansehen →
Passend zu diesem Beitrag
Forschungsprojekte
- High resolution dissection of non-coding determinants of disease While mutations at protein-coding sequences have been extensively characterized, the functional role of disea… →
- From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network Every year, around 600 children in the Netherlands get cancer and one in four children dies from this illness… →
- International Study for Treatment of Childhood Relapsed ALL 2020 Relapse of acute lymphoblastic leukemia (ALL) remains a leading cause of mortality in childhood cancer. IntRe… →
- Developmentally programmed pediatric sarcomas: a versatile platform for drug discovery and molecular precision medicine Pediatric sarcomas account for ~20% of childhood cancers. They have disappointing survival rates, with very l… →
- A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis High-risk neuroblastoma accounts for 15% of cancer related-deaths in children. Half of the >1500 patients yea… →